Denmark confirms excessive-pricing decision
Denmark’s Competition Appeals Tribunal has confirmed findings by the country’s antitrust authority that drug distributor CD Pharma abused its dominant position in the market for the distribution of a stimulant drug by raising its price by 2000%.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10